Biological: single dose of trivalent virosomal adjuvanted influenza vaccine (Inflexal® V). Total duration of follow-up: approximately three weeks.

2 trials

Sponsors

Crucell, Berna Biotech Ltd (Switzerland), Crucell Switzerland AG (Switzerland)

Conditions

Influenza Infections and Infestations Influenza, virus not identified

Unknown Phase

Assessment of the immunogenicity and safety of the Northern Hemisphere 2008/2009-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations

Active, not recruitingISRCTN40098615

Crucell, Berna Biotech Ltd (Switzerland)Influenza Infections and Infestations Influenza, virus not identified

Start: 2008-06-01Target: 110Updated: 2015-01-13

Assessment of the immunogenicity and safety of the Northern Hemisphere 2010/2011-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations

Active, not recruitingISRCTN89337058

Crucell Switzerland AG (Switzerland)Influenza Infections and Infestations Influenza, virus not identified

Start: 2010-06-01Target: 110Updated: 2023-02-20